True Pseudotumors and “Pseudo” – Pseudotumors: A Case Series

ABSTRACT

Objective: To characterize the clinical and pathological features of 4 patients with histopathology-confirmed idiopathic orbital inflammatory disease (OID) initially diagnosed as an orbital neoplasm and 9 patients with histopathology-confirmed orbital neoplasm that presented as idiopathic OID.

Methods: The medical records of 13 patients with orbital mass were reviewed. All biopsies were performed by one orbit surgeon.

Results: There were 4 patients in the histopathology-confirmed idiopathic OID group with preoperative diagnosis of orbital neoplasm. Mean age at presentation was 27 years. Follow-up period ranged from 6 to 41 months. The left orbit was predominantly involved (3/4). The presenting symptoms and signs included proptosis (2/4), diplopia (1/4), and inflammation (1/4). The preoperative best-corrected decimal acuity mean was 0.92. Three of 4 patients retained their preoperative visual acuity postoperatively. There was recurrence of inflammatory signs in only 1 patient, which responded well to oral corticosteroids. In the histopathology-confirmed orbital neoplasm with preoperative diagnosis of idiopathic OID group, there were 9 patients with mean age at presentation of 52 years. Follow-up period averaged 7.5 months (range: 0.5 – 83 months). The presenting symptoms and signs included proptosis (4/9), inflammation (3/9), orbital pain (1/9), and epiphora (1/9). The preoperative best-corrected decimal acuity mean was 0.78. Histopathology and immunohistochemistry of the orbital masses revealed malignancy in 80% (7/9) of these cases.

Conclusions: Idiopathic OID remains a diagnostic dilemma for many physicians. A detailed history, comprehensive physical examination, and appropriate radiological evaluation are essential to differentiate OID and non-inflammatory orbital conditions such as neoplasms. Biopsy is recommended when there is poor or equivocal response to steroids or suspicion of orbital malignancy.

Keywords: Pseudotumor, orbital inflammatory disease, neoplasm, biopsy, histopathology

Download PDF

Cholesterol Granuloma of the Orbit

Title: Cholesterol Granuloma of the Orbit

Published: Philippine Journal of Ophthalmology. Volume 30, No. 3 (July-September) 2005: pp 129-132

Objective:
To report a patient with cholesterol granuloma and describe the distinct clinical, radiologic, and histopathologic findings.

Methods: This is a case report.

Results:
A 33-year-old man presented with a 12-month history of diplopia on left upward gaze. He underwent repair of wound laceration at the right fronto-temporal area 25 years prior to consultation due to a head bump sustained in a vehicular accident. Examination revealed nonaxial proptosis, inferior globe displacement, and mild limitation on left upward gaze. Orbital imaging revealed an ovoid extraconal expansile soft-tissue mass in the left orbit, slightly compressing the globe inferiorly, and thinning and widening of the superior portion of the orbital wall. Excision biopsy of the orbital mass was done through a lateral orbitotomy with bone flap. Histopathology revealed characteristic features of cholesterol granuloma including abundant cholesterol clefts, foreign-body giant cells, lipid-laden histiocytes, and hemosiderin macrophages with absence of epithelial components.

Conclusion:
Orbitofrontal cholesterol granulomas have typical clinical, radiologic, and histopathologic features. Surgical incision has a high success rate with low incidence of recurrence.

The document pages (in jpg) containing the full article are below this post.

cholesterolgranuloma-p1 cholesterolgranuloma-p2 cholesterolgranuloma-p3 cholesterolgranuloma-p4

(end of document)

Conjunctival Autograft versus Primary Closure after Removal of Primary Pterygium

Title: Conjunctival Autograft versus Primary Closure after Removal of Primary Pterygium

Published: The Philippine Journal of Ophthalmology. Volume 27, No. 2 (April-June) 2002: pp 81-87

Intro: Pterygium, from the Greek word wing, is an abnormal tissue growth that invades the cornea from the bulbar conjunctiva. It is organized into three parts: (1) the “body” which is the raised triangular portion of the pterygium; (2) the “head” which forms the apex of the triangle; and (3) a subepithelial “cap” which forms the leading edge.

Prevalence is higher in people living in warm, dry climates, and those who work in an outdoor environment.

The document pages (in jpg) containing the full article are below this post.

Conjuctival-Autograft1

Conjuctival-Autograft2

Conjuctival-Autograft3

Conjuctival-Autograft4

Conjuctival-Autograft5

Conjuctival-Autograft6

Conjuctival-Autograft7

(end of document)

The Micro-Reflux Test – A New Test to Evaluate Nasolacrimal Duct Obstruction

Title: Micro-Reflux Test – A New Test to Evaluate Nasolacrimal Duct Obstruction

Published: Ophthalmology (USA). Volume 106, No. 12 (December) 1999 pp: 2319-2321

Objective: The authors describe a new and simple procedure, the Micro-Reflux Test (MRT), to screen for primary acquired nasolacrimal duct obstruction (PANDO). This study sought to determine the reliability of this new test in the diagnosis of complete nasolacrimal duct obstruction.

Design:
A nonrandomized, prospective, self-controlled comparative case series.

Participants: Two hundred eyes of 100 patients with documented unilateral complete PANDO were examined.

The document pages (in jpg) containing the full article are below this post.

Micro-Reflux-Test1 Micro-Reflux-Test2

Micro-Reflux-Test3

(end of document)

Endoscopic Laser-Assisted Dacryocystorhinostomy

Title: Surgical Technique of Endoscopic Laser-Assisted Dacryocystorhinostomy

Published. Operative Techniques in Oculoplastic, Orbital, and Reconstructive Surgery. Volume 1, No. 2 (December) 1998: pp 66-72

Caldwell described the endonasal approach to dacryocystorhinostomy (DCR) in 1893, but this approach was abandoned because of the technical complexities of the procedure. With the advent of endoscopy, there has been a renewed interest in the endonasal approach to DCR. Endoscopic laser-assisted DCR (ELA-DCR) has been the subject of much interest since its introduction in 1990 by Massaro et al. Despite its advantages, ELA-DCR has failed to become for widely accepted, clinical data have been sparse, and the effectiveness of this procedure has not been fully evaluated. The success rate of ELA-DCR in published small-series studies has ranged from 68.4% to 100%. More recently, Hartikainen et al compared the success rate and operative time between ELA-DCR and external DCR (EXT-DCR). In that report, the success rate 1 year after surgery was 91% for EXT-DCR and 63% for ELA-DCR. Their study also showed the operative time for ELA-DCR was three times shorter than that for EXT-DCR, with an average duration of 23 and 78 minutes respectively.

The document pages (in jpg) containing the full article are below this post.


dacryocystorhinostomy-1

dacryocystorhinostomy-2

dacryocystorhinostomy-3

dacryocystorhinostomy-4

dacryocystorhinostomy-p5

dacryocystorhinostomy-p6

dacryocystorhinostomy-p7

(end of file)




Diabetic Retinopathy in Non-Insulin Dependent Diabetes Mellitus

Title: Diabetic Retinopathy in Non-Insulin Dependent Diabetes Mellitus

Published. Philippine Journal of Ophthalmology. Volume 23, No. 3 (July-September) 1998: pp 116-120

Purpose: To identify the factors associated with the onset and progression of diabetic retinopathy.

Methods: One hundred fifteen (115) eyes of 59 patients were thoroughly examined for diabetic retinopathy. Baseline laboratory examinations were also performed and correlated with the ocular findings.

Results: Male sex, duration of the disease, fasting blood sugar, glysosylated hemoglobin and glucosuria were positively associated with diabetic retinopathy.

Conclusion: The importance of glycemic control on the progression of diabetic retinopathy is evident and therapeutic compliance guided by laboratory examinations is recommended.

The document pages (in jpg) containing the full article are below this post.

diabetic-retinopathy1 diabetic-retinopathy2 diabetic-retinopathy3 diabetic-retinopathy4 diabetic-retinopathy5(end of document)